NASDAQ:ABEO
$3.31
(
8.17%
)
Friday, 2nd Jun 2023
Abeona Therapeutics Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.90 | $3.45 | Friday, 2nd Jun 2023 ABEO stock ended at $3.31. This is 8.17% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 13.86% from a day low at $3.03 to a day high of $3.45. |
| 90 days | $2.24 | $3.45 | |
| 52 weeks | $2.19 | $6.13 |
Historical Abeona Therapeutics Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $3.09 | $3.45 | $3.03 | $3.31 | 236 288 |
| 2023-06-01 | $3.08 | $3.10 | $3.00 | $3.06 | 49 165 |
| 2023-05-31 | $3.08 | $3.10 | $3.00 | $3.09 | 58 648 |
| 2023-05-30 | $3.15 | $3.15 | $3.04 | $3.08 | 50 262 |
| 2023-05-26 | $3.15 | $3.22 | $3.09 | $3.14 | 98 310 |
| 2023-05-25 | $3.30 | $3.33 | $3.18 | $3.21 | 86 434 |
| 2023-05-24 | $3.17 | $3.40 | $3.08 | $3.22 | 164 689 |
| 2023-05-23 | $3.20 | $3.33 | $3.08 | $3.16 | 113 189 |
| 2023-05-22 | $3.10 | $3.39 | $3.07 | $3.24 | 417 103 |
| 2023-05-19 | $3.02 | $3.10 | $2.95 | $3.10 | 69 746 |
| 2023-05-18 | $2.97 | $3.05 | $2.93 | $2.99 | 61 118 |
| 2023-05-17 | $3.01 | $3.10 | $2.96 | $2.96 | 56 716 |
| 2023-05-16 | $3.15 | $3.15 | $3.00 | $3.03 | 28 654 |
| 2023-05-15 | $2.99 | $3.10 | $2.98 | $3.08 | 38 782 |
| 2023-05-12 | $2.96 | $3.05 | $2.90 | $2.97 | 100 362 |
| 2023-05-11 | $3.29 | $3.29 | $2.91 | $2.97 | 164 927 |
| 2023-05-10 | $3.18 | $3.34 | $3.14 | $3.20 | 102 980 |
| 2023-05-09 | $3.08 | $3.19 | $3.08 | $3.18 | 30 594 |
| 2023-05-08 | $3.32 | $3.34 | $3.07 | $3.13 | 101 003 |
| 2023-05-05 | $3.26 | $3.43 | $3.25 | $3.28 | 110 211 |
| 2023-05-04 | $3.07 | $3.29 | $3.04 | $3.26 | 97 744 |
| 2023-05-03 | $3.30 | $3.33 | $3.06 | $3.10 | 106 906 |
| 2023-05-02 | $3.17 | $3.31 | $3.16 | $3.28 | 46 985 |
| 2023-05-01 | $3.06 | $3.33 | $3.06 | $3.24 | 94 778 |
| 2023-04-28 | $3.13 | $3.19 | $3.03 | $3.07 | 80 618 |
| 2023-04-27 | $3.21 | $3.21 | $3.04 | $3.13 | 156 810 |
| 2023-04-26 | $3.23 | $3.23 | $3.06 | $3.20 | 57 680 |
| 2023-04-25 | $3.38 | $3.40 | $3.23 | $3.26 | 76 024 |
| 2023-04-24 | $3.28 | $3.44 | $3.13 | $3.39 | 328 070 |
| 2023-04-21 | $3.12 | $3.30 | $3.09 | $3.22 | 375 218 |
| 2023-04-20 | $3.14 | $3.14 | $3.00 | $3.09 | 58 824 |
| 2023-04-19 | $2.97 | $3.30 | $2.93 | $3.15 | 257 208 |
| 2023-04-18 | $2.88 | $3.04 | $2.87 | $2.93 | 147 441 |
| 2023-04-17 | $2.79 | $3.00 | $2.77 | $3.00 | 122 931 |
| 2023-04-14 | $2.77 | $2.84 | $2.73 | $2.79 | 36 094 |
| 2023-04-13 | $2.91 | $2.97 | $2.74 | $2.76 | 79 063 |
| 2023-04-12 | $3.03 | $3.03 | $2.88 | $2.91 | 57 499 |
| 2023-04-11 | $2.89 | $2.96 | $2.81 | $2.91 | 73 863 |
| 2023-04-10 | $2.84 | $2.84 | $2.73 | $2.83 | 54 290 |
| 2023-04-06 | $2.76 | $2.84 | $2.71 | $2.81 | 68 459 |
| 2023-04-05 | $2.78 | $2.84 | $2.75 | $2.81 | 47 275 |
| 2023-04-04 | $2.76 | $2.86 | $2.75 | $2.82 | 31 090 |
| 2023-04-03 | $2.82 | $2.92 | $2.76 | $2.83 | 168 136 |
| 2023-03-31 | $2.85 | $2.96 | $2.77 | $2.82 | 132 421 |
| 2023-03-30 | $2.74 | $2.90 | $2.72 | $2.83 | 135 450 |
| 2023-03-29 | $2.79 | $2.85 | $2.65 | $2.81 | 108 762 |
| 2023-03-28 | $2.73 | $3.09 | $2.72 | $2.78 | 218 893 |
| 2023-03-27 | $2.80 | $2.80 | $2.61 | $2.72 | 69 425 |
| 2023-03-24 | $2.39 | $2.83 | $2.39 | $2.71 | 212 993 |
| 2023-03-23 | $2.40 | $2.51 | $2.36 | $2.43 | 72 772 |
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
